lupus.bmj26m
Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report
Objective Combination therapy with rituximab and belimumab is a novel treatment strategy for severe SLE and lupus nephritis.
lupus.bmj30m
Time trends of variability in disease activity in systemic lupus erythematosus
Objective Disease activity both between and within patients with SLE is highly variable, yet factors driving this variability ...